-
Kenealy, M, Benson, W, Stevenson, W, Eek, R, Zantomio, D, Cunningham, I, Hiwase, D, Cowan, L, Vlachos, S, Zannino, D, et al.
13 THE ADDITION OF LENALIDOMIDE TO AZACITIDINE ACHIEVES HIGHER RESPONSES BUT NO IMPROVEMENT IN TWELVE MONTH CLINICAL BENEFIT OR PFS; MAIN ANALYSIS AUSTRALIAN ALLG MDS4 TRIAL.
Leukemia Research
39:
s5
2015
view publication
-
Kashyap, R, Hofman, MS, Michael, M, Kong, G, Akhurst, T, Eu, P, Zannino, D, Hicks, RJ.
Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours.
European Journal of Nuclear Medicine and Molecular Imaging
42(2)
:
176 -185
2015
view publication
-
Wetzig, N, Gill, PG, Zannino, D, Stockler, MR, Gebski, V, Ung, O, Campbell, I, Simes, RJ.
Sentinel Lymph Node Based Management or Routine Axillary Clearance? Three-year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial.
Annals of Surgical Oncology
22(1)
:
17 -23
2015
view publication
-
Elmadahm, AA, Gill, PG, Bochner, M, Gebski, VJ, Zannino, D, Wetzig, N, Campbell, I, Stockler, M, Ung, O, Simes, J, et al.
Sentinel lymph node in the SNAC‐1 trial.
ANZ Journal of Surgery
85(1-2)
:
58 -63
2015
view publication
-
Mendis, R, Soo, W-K, Zannino, D, Michael, N, Spruyt, O.
Multidisciplinary Prognostication Using the Palliative Prognostic Score in an Australian Cancer Center.
Palliative Care and Social Practice
9:
pcrt.s24411
2015
view publication